Notably, this study identified numerous novel epigenetic markers associated with both T2D and HbA1c and could technically validate lower methylation of CDKN1A, HDAC4, TXNIP, and RHOT1 in T2D islets. The gene discussed is CDKN1A; the disease is type 2 diabetes mellitus.